MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Reason
April 2001
Ronald Bailey
Goddamn the Pusher Man Why does everybody seem to hate the pharmaceutical industry? mark for My Articles similar articles
Searcher
June 2012
Stephanie C. Ardito
The Medical Digital: How Safe Are the Prescription Drugs we Take? Monitoring Adverse Events and Recalls For general information about prescription and clinical trial drugs, the following websites have been around for a while and have excellent reputations. mark for My Articles similar articles
Managed Care
February 2007
MargaretAnn Cross
How Much Trouble Does Health Care Marketing Cause? Whether for drugs, imaging, surgery, or emergency services, direct-to-consumer advertising sparks lively debate. mark for My Articles similar articles
Salon.com
July 11, 2000
Ina May Gaskin
Cytotec: Dangerous experiment or panacea? Doctors are prescribing an unapproved, unpredictable ulcer drug to induce labor in thousands of women. Why are women the last to know? mark for My Articles similar articles
CFO
Kris Frieswick
Clinical Trials A new kind of pricing pressure puts pharmaceutical CFOs in an unfamiliar role: evangelist... mark for My Articles similar articles
The Motley Fool
September 30, 2010
Brian Orelli
Avoid This Multibillion-Dollar Market It's just too crowded, but there's no doubt that psychiatric drugs are big business for some drugmakers. mark for My Articles similar articles
Mother Jones
February 2000
David Goodman
Forced Labor Why are obstetricians speeding deliveries with an ulcer drug that endangers mothers and their babies? mark for My Articles similar articles
The Motley Fool
May 21, 2010
Brian Orelli
And You Thought Biotech Was High-Risk, High-Reward Large clinical trials make cardiovascular drugs risky, but the rewards are there, too. mark for My Articles similar articles
The Motley Fool
January 27, 2011
Rich Smith
What's Behind the Run-Up at Rexahn? The pharmaceutical's hot streak could soon burn up all its cash. mark for My Articles similar articles
The Motley Fool
April 22, 2011
Sean Williams
Pharma's Most Perilous Pipelines Patent expirations expose weaknesses for these Wall Street darlings. mark for My Articles similar articles
The Motley Fool
February 25, 2010
Brian Orelli
An Untouched Market Waiting to Be Captured Unfilled prescriptions are a potential boon to drug companies. mark for My Articles similar articles